Literature DB >> 3003346

Role of 5'-nucleotidase in adenosine-mediated renal vasoconstriction during hypoxia.

A Ramos-Salazar, A D Baines.   

Abstract

Regulation of renal function by endogenous adenosine production was examined in isolated perfused rat kidneys. Reducing perfusate pO2 from 400 +/- 15 to 130 +/- 5 mm Hg for 20 min created an energy deficit and increased adenosine in venous perfusate (0.06 +/- 0.02 to 0.79 +/- 0.15 microM) and snap-frozen renal cortex (5.6 +/- 1.4 to 16.7 +/- 2.7 nmol/g wet wt.). A competitive inhibitor of 5'-nucleotidase, alpha,beta-methyleneadenosine diphosphate (120 microM), inhibited the production of adenosine during hypoxia (perfusate, 0.26 +/- 0.05 microM and renal cortex, 3.1 nmol/g) but did not prevent the decline in cortical tissue ATP and ADP. The inhibitor was concentrated 3-fold in renal cortex compared to perfusate and could therefore inhibit both ecto and endo 5' nucleotidases. Vascular resistance increased 11.1 +/- 0.5% during hypoxia. Inhibition of 5'-nucleotidase reduced the vasoconstrictive response by 40% (P less than .01). An A1 antagonist, 1,3-diprophyl-8-(2-amino-4-chlorophenyl)xanthine (10(-5) M), reduced the effect of hypoxia on vascular resistance by 60% (P less than .005). Adenosine deaminase (7-14 U/ml) added during hypoxia reduced venous adenosine from 1.0 to 0.3 microM and reduced vascular resistance by 3 +/- 1%. Neither the inhibitors nor adenosine deaminase significantly altered the response of glomerular filtration rate or sodium reabsorption to hypoxia. These results indicate that either ecto or endo 5'-nucleotidase controls the renal production of adenosine during an energy deficit and that endogenous adenosine constricts the renal vasculature.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3003346

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  9 in total

1.  Immunolocalization of ecto-5'-nucleotidase in the kidney by a monoclonal antibody.

Authors:  R Gandhi; M Le Hir; B Kaissling
Journal:  Histochemistry       Date:  1990

2.  Oxygen-dependent erythropoietin production by the isolated perfused rat kidney.

Authors:  H Scholz; H J Schurek; K U Eckardt; A Kurtz; C Bauer
Journal:  Pflugers Arch       Date:  1991-04       Impact factor: 3.657

3.  A randomised, double blind, placebo controlled trial of the effect of theophylline in prevention of vasomotor nephropathy in very preterm neonates with respiratory distress syndrome.

Authors:  D Cattarelli; M Spandrio; A Gasparoni; R Bottino; C Offer; G Chirico
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-10-04       Impact factor: 5.747

Review 4.  Role of erythropoietin in adaptation to hypoxia.

Authors:  H Scholz; H J Schurek; K U Eckardt; C Bauer
Journal:  Experientia       Date:  1990-12-01

5.  Differential cardioprotection with selective inhibitors of adenosine metabolism and transport: role of purine release in ischemic and reperfusion injury.

Authors:  A S Abd-Elfattah; M E Jessen; J Lekven; A S Wechsler
Journal:  Mol Cell Biochem       Date:  1998-03       Impact factor: 3.396

6.  The soluble 'low-Km' 5'-nucleotidase of rat kidney represents solubilized ecto-5'-nucleotidase.

Authors:  G Piec; M Le Hir
Journal:  Biochem J       Date:  1991-01-15       Impact factor: 3.857

7.  Impairment of tubuloglomerular feedback regulation of GFR in ecto-5'-nucleotidase/CD73-deficient mice.

Authors:  Hayo Castrop; Yuning Huang; Seiji Hashimoto; Diane Mizel; Pernille Hansen; Franziska Theilig; Sebastian Bachmann; Chuxia Deng; Josie Briggs; Jurgen Schnermann
Journal:  J Clin Invest       Date:  2004-09       Impact factor: 14.808

8.  Endogenous adenosine is an autacoid feedback inhibitor of chloride transport in the shark rectal gland.

Authors:  G G Kelley; O S Aassar; J N Forrest
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

9.  Adenosine produced via the CD73/ecto-5'-nucleotidase pathway has no impact on erythropoietin production but is associated with reduced kidney weight.

Authors:  Burcin Ozüyaman; Zhaoping Ding; Anja Buchheiser; Patrycja Koszalka; Norbert Braun; Axel Gödecke; Ulrich K M Decking; Herbert Zimmermann; Jürgen Schrader
Journal:  Pflugers Arch       Date:  2006-02-09       Impact factor: 3.657

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.